Use of a BRCA1 peptide validates MS110 as a BRCA1-specific antibody in immunohistochemistry

Histopathology

Volumn 53, Issue 1, 2008, Pages 117-120

  Alamshah, A ^a   Springall, R ^b   Gillett, C E ^b   Solomon, E ^a   Morris, J R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; MS110 ANTIBODY; PROTEIN ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL;

ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; TUMOR MARKERS, BIOLOGICAL;

EID: 45549097168     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03049.x     Document Type: Letter

References (12)

1. Catteau A, Morris JR. BRCA1 methylation: a significant role in tumour development? Semin. Cancer Biol. 2002 12 359 371.
2. Turner NC, Reis-Filho JS, Russell AM et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 2007 26 2126 2132.
3. Perez-Valles A, Martorell-Cebollada M, Nogueira-Vazquez E, Garcia-Garcia JA, Fuster-Diana E. The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study. J. Clin. Pathol. 2001 54 476 480.
4. Chambon M, Nirde P, Gleizes M, Roger P, Vignon F. Localization of BRCA1 protein in human breast cancer cells. Breast Cancer Res. Treat. 2003 79 107 119.
5. Scully R, Ganesan S, Brown M et al. Location of BRCA1 in human breast and ovarian cancer cells. Science 1996 272 123 126.
6. Yoshikawa K, Honda K, Inamoto T et al. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin. Cancer Res. 1999 5 1249 1261.
7. Wilson CA, Ramos L, Villasenor MR et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 1999 21 236 240.
8. Elstrodt F, Hollestelle A, Nagel JH et al. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 2006 66 41 45.
9. Xu CF, Chambers JA, Solomon E. Complex regulation of the BRCA1 gene. J. Biol. Chem. 1997 272 20994 20997.
10. Sobczak K, Krzyzosiak WJ. Structural determinants of BRCA1 translational regulation. J. Biol. Chem. 2002 277 17349 17358.
11. Lambie H, Miremadi A, Pinder SE et al. Prognostic significance of BRCA1 expression in sporadic breast carcinomas. J. Pathol. 2003 200 207 213.
12. Abd El-Rehim DM, Ball G, Pinder SE et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int. J. Cancer 2005 116 340 350.